Learn how surgeons are using AI to help them perform safe and effective procedures and overcome the backlog of surgery.
List of pages

King’s Health Partners and The Lancet announce Global Commission on Sepsis
4 February 2026
The international commission will focus on improving the diagnosis, management, and treatment of sepsis – a life-threatening condition affecting millions each year.
-
8 July 2020
-
3 July 2020News
Prof Richard Trembath has been appointed as Executive Director of King’s Health Partners and will begin his role on 1 September 2020.
-
2 July 2020News COVID-19
Find out how GPs and primary care adapted and modernised the way they cared for patients in response to COVID-19.
-
1 July 2020Blog Mind and Body blog
Boryana Smilenova, from our Mind & Body team talks about what it means to be part of our network of more than 850 advocates.
-
17 June 2020Blog COVID-19 Mind and Body blog
Learn how virtual meetings and Mindapples’ wellbeing principles keep people with learning disabilities connected during lockdown.
-
17 June 2020News COVID-19 Allergy Respiratory Critical Care Anaesthetics and Pain
A trial of a unique formulation of ibuprofen treatment for treating severe acute respiratory distress syndrome (ARDS) has launched.
-
17 June 2020News COVID-19
The Life Lines project has now delivered more than 1,100 tablets to connect families with their loved ones through the COVID-19 pandemic.
-
15 June 2020News Mind & Body
Our Mind & Body team have launched their first Learning Disability Strategy to help bridge a 16-year mortality gap.
-
15 June 2020News COVID-19
Dr Yijing Li, Lecturer in Urban Informatics at King’s College London, discusses the team effort crucial to our COVID-19 response.
-
15 June 2020News COVID-19
A partnership between King’s Health Partners’ organisations and 3D printing manufacturers is helping supply face shields for staff.
-
15 June 2020News COVID-19
We explore how King's Health Partners is working to ensure healthcare workers can access the support they need.
-
2 June 2020News COVID-19
A new trial repurposing a blood cancer drug for patients with COVID-19 is being launched.
